PHAT

Phathom Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company based in Florham Park, New Jersey, focused on developing and commercializing innovative therapies for gastrointestinal disorders. With a robust pipeline aimed at addressing significant unmet medical needs, Phathom is poised to make a meaningful impact on patient care. The company's commitment to clinical development and potential product launches position it for substantial growth, making it an appealing investment opportunity for institutional investors seeking to capitalize on advancements in the biopharmaceutical sector.